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Under the 
skin:
Russia’s budding healthcare crisis
By Madeline Kehl
Behind the ghost of the Iron Curtain lurks a public health crisis. Superceded 
in the media by East-West tension and 
military flare-ups, infectious disease 
has launched its own war on the Rus-
sian Federation. Besides the HIV epi-
demic, which has continued to escalate 
for decades, the Russian Federation has 
become a greenhouse for multidrug 
resistant tuberculosis (MDR TB). This 
problem is not just a problem of the 
Russian Federation, but has worldwide 
significance due to the spread of resis-
tant TB. Furthermore, the issue has not 
received the attention it deserves from 
the international media or the Rus-
sian government.  MDR-TB in Russia 
needs to be taken more seriously. 
The cocktail of factors that ag-
gravate the epidemic in the Russian 
Federation is unlike that of any other 
country. The Russian Federation has 
inadequate programs to treat MDR-
TB. In addition, its reluctance to accept 
international aid and a lack of under-
standing of the HIV-TB coinfection 
pervades the culture. A successful 
strategy towards fighting TB in the 
Russian Federation must therefore 
attack on a biological, infrastructural 
and political front. The pathogenesis 
of TB, economic problems that a post 
USSR Russian Federation faces inter-
nally, and the external tensions that the 
post-USSR Russian Federation faces 
must be taken into consideration. 
The Russian Federation has the 
11th highest rate of tuberculosis infec-
tion in the world. Even more alarming 
is the fact that the percentage of these 
infections that are classified as multi-
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drug resistant tuberculosis (MDR-TB) 
is estimated to be well over 10%, the 
third highest global rate. MDR-TB has 
become resistant to medications nor-
mally used to treat TB, isoniazid and 
rifampicin. XDR-TB is a form of tu-
berculosis resistant to even more drugs 
than MDR-TB.1   In the Russian Fed-
eration, the XDR variant comprises 
up to a quarter of MDR-TB cases.  It is 
possible that these figures exceed what 
is predicted because collecting reliable 
data is difficult as a result of the varia-
tion in resource-distribution through-
out the country.2
Mycobacterium tuberculosis com-
plex history in human society.  For 
centuries people have struggled with it 
and have tried to eradicate it like they 
have smallpox. While the disease is 
now treatable via antibiotics, and while 
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a vaccine, which shows moderate suc-
cess, exists (BCG Vaccine), scientists 
are still searching for a more compre-
hensive way of preventing and com-
bating the disease. 
The development of MDR TB pres-
ents scientists with new challenges. 
When people become infected with 
TB, in 95% of cases, the immune sys-
tem contains it in a latent form. This 
is a state where the bacterium is dor-
mant, and the person presents with no 
symptoms and is usually not conta-
gious.  This is also a state from which 
the bacterium can emerge.  If treat-
ment was improper the initially, with 
inconsistent drug supply and varying 
enforcement (a phenomenon very fre-
quent in the Russian Federation) it can 
develop resistance to the medications 
and reactivate into MDR-TB.  More ef-
fective vaccines are currently in trials, 
but there are years, money, and politics 
between those drugs and the sick pop-
ulation of the Russian Federation.3
Healthy immune systems are of-
ten capable of defending themselves 
against TB. Even if the body of an 
infected person does not complete-
ly kill the bacteria, there’s only a 10% 
per life chance of reactivation for a 
healthy person.4 However, not every-
one is healthy. People in poverty, as a 
group, are among those clinically more 
likely to have increased susceptibility 
to infection.  Reasons for this include 
poor nutrition, crowded living condi-
tions, stress, and its resulting substance 
abuse. For example alcoholism, a ma-
jor problem in the Russian Federation, 
is a known compromiser of the human 
immune system.5
Russian prisons have also emerged 
as a problem area in the containment 
MDR-TB.  This is due to lack of access 
to health care and medications as well 
as prison over-crowding.  The 2010 
bulletin of the World Health Organi-
zation (WHO) described the situation 
as “Virtually every prisoner [being] 
exposed to tuberculosis. Many became 
sick, many died, and thousands of in-
fected ex-convicts were being released 
into the general population every 
year”.6  In some areas inmates must fol-
low sleeping rotations to make up for 
the lack of space for beds.7  This envi-
ronment is extremely conducive to the 
spread of airborne pathogens, such as 
tuberculosis.   
Not only does the disease infect in-
mates, it infects wardens, prison guards, 
visitors, and other workers who then 
transmit to the general population.  It 
also infects people being held in prison 
detention centers.  Because of the inef-
ficacy of the Russian judicial system, 
thousands of people each year are de-
tained for minor crimes (such as petty 
theft) and end up incarcerated for years 
before their case even comes to court. 
In these years, they receive a death 
sentence in the form of MDR TB.  A 
significant percentage of inmates sur-
vive to return home, bringing MDR-
TB along. The inmates, though they 
may seem like an isolated minority, 
directly impact the overall health of the 
nation.8  Unfortunately, finding a satis-
factory way of dealing with TB in such 
settings is challenging. International 
aid has met with failure in this area. 
In 2006 the WHO initiated its Stop 
TB strategy.  One of the major pillars 
of this strategy is a plan called DOTS, 
or Directly Observed Treatment Short 
Course. In some areas, such as the Sa-
mara Oblast, this strategy has been im-
plemented with success, minimizing 
hospital stays and making treatment 
overall more cost effective.9 However, 
these results aren’t universal.  In the 
1990s, DOTS failed.  Local clinicians 
distrusted it and often implemented 
it incorrectly.  Furthermore some of 
the steps simply were not designed for 
MDR-TB. DOTS focused on treating 
TB in a “short course” which led to 
treatment being stopped prematurely. 
This contributed to the development 
of MDR-TB in many patients.  Tuber-
culosis was not stopped, it became the 
leading cause of death in prisons, and 
they abandoned the policy.10  Whatev-
er the government decides to do now, 
a repeat of what happened with DOTS 
must not occur. DOTS was a generic 
system designed for generic TB that 
did not adequately address the issues 
at hand in Russia.  It discredited inter-
national health policies in Russia, and 
was essentially a waste of resources. 
HIV (human immunodeficiency 
virus) is another major factor in the 
development of MDR-TB.  MDR-TB 
has spread so easily and so rapidly 
among the Russian Federation popula-
tion in part because it co-infects with 
HIV, a disease which, over the past few 
decades has ravaged the country.11  For 
example, people infected with HIV see 
their chances of reactivation of latent 
TB increase from 10% per life to 10% 
per year.12  HIV leads to immunosup-
pression due to the destruction of CD4 
T cells (an essential part of the adaptive 
immune system), thereby increasing 
susceptibility to TB infection. When 
HIV takes these cells out, there’s little 
to stop TB coming in.  The correlation 
between HIV and TB is so well es-
tablished that the WHO now collects 
separate data on the coinfections, in 
addition to what they collect on the 
diseases individually. 
While HIV has seen more media 
attention than MDR TB, the problem 
is still largely out of sight and out of 
mind — exactly where the conservative 
government of the Russian Federation 
wants it to be.  Intravenous drug use is 
the method by which 57% of the Rus-
sian Federation’s current HIV infected 
population acquired the disease. In 
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the Russian Federation, heroin prices 
have been declining since the nineties 
due to the collapse of border security 
between Russia and Middle Eastern 
poppy fields and HIV has increased 
significantly due to the increase in 
drug use.13  With regards to drug ad-
diction, the Russian Federation has not 
adopted evidenced-based approach-
es used in most Western countries 
including harm reduction measures 
such as syringe exchange and metha-
done treatment on moral grounds. The 
Russian Federation government’s un-
willingness to follow Western example, 
combined with the strength of the Or-
thodox Church in policy making, has 
led to a halt in preventative measures 
when it comes to severing the tie be-
tween addiction and HIV. Registering 
as a heroin addict in the country comes 
with severe consequences and NGOs 
are penalized for trying to instate 
methadone or clean needle programs. 
When nothing is being done to protect 
the populations at risk for HIV, it trans-
lates to nothing being done to protect 
them from developing infections like 
MDR-TB.  And unlike HIV, MDR-TB 
is airborne, and can target a much wid-
er range of people.14
Given the instability that the coun-
try has seen in the past few decades, 
it is not surprising that the Russian 
Federation’s government would be de-
fensive of their policies, especially on 
ideological points where they differ 
from the West.15  With all the work that 
the government has done to reinstate 
the Russian Eastern Orthodox Church 
and try to preserve the image of mor-
al superiority to the West, it is unlikely 
that they would cast this identity aside 
and assume a Western stance for the 
sake of helping the stereotypical at-risk 
HIV infected population--one of sex 
workers and drug addicts.16  While one 
can sympathize with The Russian Fed-
eration stance, an attempt to preserve 
a moral code, one must also recognize 
the perverseness of the “moral code” as 
it results in death.  HIV in the Russian 
Federation is flourishing. In 1997 there 
were barely over 11,000 official cases 
of HIV total. 41,707 people were reg-
istered as HIV positive in just the first 
half of 2015.17,18 These rates are un-
heard of in the developed world. The 
number of people with HIV continues 
to rise in a way that has been compared 
to that of epidemics in Africa.19 HIV 
opens its victims to a range of infec-
tions, of which TB is one.   
Inequity in access to treatment is a 
contributing factor in both the epidem-
ics of HIV and TB in the Russian Fed-
eration. The sickest of people are those 
who can least afford treatment. The 
Russian Federation has state healthcare 
in name, but that healthcare has dete-
riorated significantly in recent years.20 
Although the national GDP has only 
risen since the fall of the Soviet Union, 
this does not mean that quality of life of 
the average person has risen.  The top 
110 people in the country hold 35% of 
the nation’s wealth, while 93.7 percent 
have less than $10,000 in savings.  This 
is largely attributed to the rapid eco-
nomic change that followed the USSR’s 
collapse.21  Behind the face of power 
and sophistication that the Russian 
Federation exhibits in its metropolises 
the country has many regions that are 
underdeveloped and underserved. The 
Moscow Times reported in April of 
2015 “According to the State Statistics 
Service, from 2005 to 2013 the number 
of health facilities in rural areas fell by 
75 percent, from 8,249 to 2,085. That 
number includes a 95 percent drop in 
the number of district hospitals, from 
2,631 to only 124, and a 65 percent 
decline in the number of local health 
clinics, from 7,404 to 2,561”.22  Indeed, 
following the collapse of the Soviet 
Union, health care in the Russian Fed-
eration faced the choice of staying cen-
tralized and state-owned or becoming 
decentralized and privatized. In the 
end, they compromised.  However, this 
compromise can result in inefficiency 
and miscommunications.  The Russian 
Federation’s constitution still guaran-
tees “free and universal healthcare.” 
At the same time starting in 2005, less 
than 10% of people qualify for the drug 
reimbursement program.  This means 
90% have to pay for prescription drugs 
out of pocket.23   Access to medications 
is a serious problem in Russia.24  On 
top of this, spending on public health 
is not being made a priority.  Between 
2010 and 2013 spending on public 
health has gone from 6.9 to 6.5 per-
cent of the GDP overall.  Spending by 
the state on public health went from 
3.7 to 3.1 percent of the GDP in that 
time frame.  These rates are lower than 
most of the developed world (Spain is 
at 8.9% total/6.3% public, the UK at 
9.1%/7.6%).25  Considering the coun-
try is facing several crises in health, this 
trend is incomprehensible. 
Unfortunately, resistance to inter-
national aid also pervades the culture. 
University of San Francisco Medical 
School describes the situation as “[The 
Russian Federation] not consider[ing] 
themselves a third-world or develop-
ing country and take great offense at 
being treated as such. Because of this, 
it can be frustrating and difficult for a 
foreigner to work in the Russian Fed-
eration (perhaps all of the FSU[Former 
Soviet Union]): they find themselves 
simultaneously confronted with dire 
circumstances, inability of the people 
to make any changes without the direc-
tion of the government, and resistance 
from the government to accept either 
the circumstances or the foreign offers 
to help”.26
Ironically, the Russian Federation 
pitt political review40
has been advertised in internation-
al media as an “emerging donor.” It is 
clear that it wants to appear as an inde-
pendent and strong nation capable not 
only of managing its own affairs, but 
aiding in the management of others. 
Mortality rates of HIV infected per-
sons with tuberculosis demonstrate the 
irony of the situation. Between 2004 
and 2012, the country was less success-
ful in reducing these rates than Chad, 
Uganda, India, and other high-burden 
nations.27  This contradiction reveals a 
serious reversal of priorities.  The me-
dia plays the Russian Federation’s bluff 
instead of calling it, and the human cost 
is astronomical.  Not enough funds are 
going towards battling the epidemic. 
The Russian Federation, in truth, 
cannot be considered a developing 
country in the way that India or Chad 
might be considered. It is more of an 
‘underdeveloped-developed’ country. 
The Russian Federation is the ghost of 
a superpower.  For centuries, the Rus-
sians have contributed to Western sci-
ence, art, and philosophy. One could 
even argue that they have the poten-
tial to have the resources necessary to 
combat this crisis in the modern day. 
But these resources are misallocated. 
Military spending his skyrocketed to 
$87.8 billion dollars, up from less than 
$1 billion in 1993 at the expense of 
healthcare, among other things.28  If a 
fraction of that were turned towards 
addressing the TB crisis, considerable 
progress could be made.  But the Rus-
sian Federation has other priorities, 
and as a result is doing its people a dis-
service. 
Solving the problem would not be 
easy and it would take full governmen-
tal commitment.  Given the geograph-
ical makeup of the Russian Federation, 
a totally uniform centralized system 
is unrealistic. The great variation in 
regional severity of the disease in con-
junction with the already-established 
local protocols make completely rein-
venting the wheel illogical.  It would be 
inefficient and lead to conflict between 
the old way and the new.  However, it 
is clear that a basic nationwide orga-
nization is needed. In order to try to 
prevent more TB from evolving into 
MDR TB, the current treatment plans 
must be enforced with greater scrutiny. 
In order for this to happen, the nation-
al pharmaceutical companies must be 
regulated and potentially subsidized 
so that they produce standard anti-TB 
medications at lower prices. A regular 
and reliable system for shipping the 
necessary medications where they are 
needed must be instated so that they 
can be taken regularly by the infect-
ed.  Eliminating inefficiencies present 
in the process of manufacturing and 
disseminating drugs would save many 
lives and stall the exponential growth 
of MDR TB.   
In order to determine the relative 
needs of each region, they would have 
to be evaluated on a standard national 
scale.  This scale would determine the 
resources that the national govern-
ment would invest in each area based 
on the needs of the area in question. 
At the same time, local experts would 
have to develop a more specific plan 
based on local conditions and avail-
ability of resources. A hospital in Mos-
cow would operate in a different way 
than a clinic in the backwoods of Si-
beria.  This would ensure that an ill-fit 
system was not put in place that might 
exacerbate the situation.  Each region 
ought to have an emergency commit-
tee comprised of both people trained 
in a basic national strategy with basic 
ground rules (minimizing hospital 
stay, ensuring proper administration of 
treatment, face masks for those infect-
ed), working in conjunction with local-
ized specialists to equip hospitals with 
exactly what they need to combat the 
disease.  In this way, the local experts 
would not be undermined, and the na-
tional strategy could be kept a realistic 
and effective standard.  
The changes that need to be made 
run deep within the core of the country 
and will take a massive investment of 
money, attention, and will.  Contain-
ment of the disease is possible if given 
the proper attention. But it has to come 
from within Russia. Eventually, the 
government is going to have to face the 
fact that it will be governing an empty 
country.  If they do not embrace it now, 
they will have to embrace it millions of 
deaths from now, when the scale and 
cost of the problem have soared.  How-
ever, no one can make that decision for 
them.  International aid is not likely to 
be offered to the Russian Federation 
in the near future, nor should it be. 
Anything that appears to be patron-
izing will likely be thrown back in the 
“benefactor’s” face. Furthermore, given 
the attitude towards foreigners (espe-
cially Westerners) within the Russian 
Federation at this time, an outsider 
could not gain the cultural knowledge 
and connections to implement suffi-
cient change. Unlike a country where 
NGOs and foreign aid may operate 
unrestrained, in the Russian Feder-
ation, there is culturally much more 
resistance to help and there exists a 
mire of bureaucracy to wade through. 
The Russian Federation has educat-
ed specialists of its own who, if given 
the resources (which could be made 
available by their own country), could 
come up with effective strategies, and 
have them better implemented than an 
outsider.  Although MDR TB threatens 
global health, and the citizens of the 
world will be impacted by the results of 
this crisis, it is currently the fight of the 
Russian Federation.   
This does not mean that there is 
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nothing for outsiders to do. Research 
ought to continue on the bacteria and 
development of the disease in the Rus-
sian Federation and throughout the 
world.  Understanding how TB devel-
ops and finding a more suitable vaccine 
or antibiotic than those already in use 
will truly benefit all of humanity. In the 
long run, it will make treatment much 
easier and cost effective and indirectly 
help all nations.   
However even if a miracle cure 
for all strains of TB were discovered it 
would not help the Russian Federation 
as it is today.  No medication can treat 
without money to buy it, a system to 
administer it, and people to support it. 
In order for the country to heal itself, 
it needs to change its attitude towards 
the epidemic and the people impact-
ed by it.  The crisis simply is not being 
given the attention it demands, and if 
this continues, the cost will be incon-
ceivable.  
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